Abstract

Immune-mediated disorders encompass a spectrum of conditions characterized by dysregulated immune responses, leading to chronic inflammation, tissue damage, and autoimmune pathology. Cytokines, the signaling molecules of the immune system, play a central role in orchestrating these aberrant immune responses. Anticytokine antibodies have emerged as a potent therapeutic strategy for modulating cytokine signaling and alleviating disease burden in immune-mediated disorders. This abstract explores the therapeutic potential of anticytokine antibodies, highlighting their mechanisms of action, clinical applications, and future directions. By selectively targeting specific cytokines implicated in disease pathogenesis, anticytokine antibodies offer precision therapy with the potential to transform the management of immune-mediated disorders, improving patient outcomes and quality of life.